| 标题 |
Senti-202, a Selective, Off-the-Shelf, Preclinical CAR-NK Cell Therapy with CD33 and/or FLT3 Activating CAR, Healthy Cell Protection from Endomucin (EMCN) Inhibitory CAR and Calibrated Release IL-15 for Hematologic Malignancies Including AML |
| 网址 | |
| DOI |
10.1182/blood-2022-157453
doi
|
| 其它 |
期刊:Blood 作者:Brian Garrison; Han Deng; Gozde Yucel; Nicholas W. Frankel; Russell Gordley; et al 出版日期:2022-11-15 |
| 求助人 | |
| 下载 | 求助已完成,仅限求助人下载。 |
PDF的下载单位、IP信息已删除
(2025-6-4)